Related references
Note: Only part of the references are listed.Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Equilibrium Angiotensin Metabolite Profiling in Patients with Acute Respiratory Distress Syndrome Indicates Angiotensin-Converting Enzyme Inhibition
Katharina Krenn et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
Michael R. Garvin et al.
ELIFE (2020)
Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly et al.
LANCET RESPIRATORY MEDICINE (2020)
Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction
Christina Binder et al.
HYPERTENSION (2019)
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Ratnadeep Basu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
Zhen Zou et al.
NATURE COMMUNICATIONS (2014)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Share Paper
